Healthequity Inc (NASDAQ:HQY) – Investment analysts at KeyCorp decreased their Q1 2019 earnings estimates for Healthequity in a report issued on Wednesday, April 4th. KeyCorp analyst D. Hooker now forecasts that the company will post earnings of $0.22 per share for the quarter, down from their previous estimate of $0.23. KeyCorp has a “Overweight” rating and a $72.00 price target on the stock.
A number of other brokerages have also recently issued reports on HQY. SunTrust Banks lifted their price objective on shares of Healthequity to $70.00 and gave the company a “buy” rating in a research note on Tuesday, March 20th. Oppenheimer lifted their price objective on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. JPMorgan Chase decreased their price objective on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $68.00 price objective on the stock in a research note on Tuesday, April 3rd. Finally, Barrington Research lifted their price objective on shares of Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Healthequity has a consensus rating of “Buy” and a consensus price target of $66.50.
Shares of NASDAQ:HQY opened at $62.82 on Monday. The company has a market capitalization of $3,829.00, a P/E ratio of 116.33, a PEG ratio of 2.52 and a beta of 1.39. Healthequity has a 1 year low of $40.21 and a 1 year high of $68.75.
Healthequity (NASDAQ:HQY) last announced its earnings results on Monday, March 19th. The company reported $0.06 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.06. Healthequity had a net margin of 20.64% and a return on equity of 13.47%. The company had revenue of $60.44 million for the quarter, compared to analysts’ expectations of $58.46 million.
In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the firm’s stock in a transaction that occurred on Monday, January 22nd. The shares were sold at an average price of $48.00, for a total value of $456,000.00. Following the sale, the vice president now owns 99,500 shares in the company, valued at $4,776,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Ashley Dreier sold 12,000 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $52.00, for a total transaction of $624,000.00. Following the completion of the sale, the vice president now owns 17,652 shares in the company, valued at approximately $917,904. The disclosure for this sale can be found here. Insiders sold 735,081 shares of company stock worth $39,413,118 in the last 90 days. Company insiders own 29.00% of the company’s stock.
Several large investors have recently modified their holdings of the company. Grandeur Peak Global Advisors LLC lifted its holdings in shares of Healthequity by 151.4% during the fourth quarter. Grandeur Peak Global Advisors LLC now owns 25,325 shares of the company’s stock worth $1,182,000 after purchasing an additional 15,250 shares during the period. Xact Kapitalforvaltning AB acquired a new position in shares of Healthequity during the fourth quarter worth $220,000. Westover Capital Advisors LLC acquired a new position in shares of Healthequity during the fourth quarter worth $702,000. MetLife Investment Advisors LLC acquired a new position in shares of Healthequity during the fourth quarter worth $1,090,000. Finally, Two Sigma Securities LLC acquired a new position in shares of Healthequity during the fourth quarter worth $208,000. Institutional investors own 99.38% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/09/q1-2019-earnings-forecast-for-healthequity-inc-hqy-issued-by-keycorp.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.